These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22075185)

  • 21. Silencing polyglutamine degeneration with RNAi.
    Bonini NM; La Spada AR
    Neuron; 2005 Dec; 48(5):715-8. PubMed ID: 16337909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells.
    Ross CJ; Ralph M; Chang PL
    Exp Neurol; 2000 Dec; 166(2):276-86. PubMed ID: 11085893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks.
    McMenamin MM; Wood MJ
    Gene Ther; 2010 Apr; 17(4):448-58. PubMed ID: 20147982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity surgery: a word of neurologic caution.
    Kumar N
    Neurology; 2007 May; 68(21):E36-8. PubMed ID: 17515535
    [No Abstract]   [Full Text] [Related]  

  • 25. [Progress in the study of neurodegenerative diseases].
    Salamanca-Gómez F
    Gac Med Mex; 2001; 137(5):487-8. PubMed ID: 11692818
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases.
    Migliore L; Coppedè F
    Mutat Res; 2009 Jul; 667(1-2):82-97. PubMed ID: 19026668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management.
    Kidd PM
    Altern Med Rev; 2005 Dec; 10(4):268-93. PubMed ID: 16366737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current state of the management of LSDs.
    Germain DP; Aggio M
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S61-2. PubMed ID: 20040313
    [No Abstract]   [Full Text] [Related]  

  • 29. Focus on neurodegeneration.
    Cho M
    Nat Neurosci; 2010 Jul; 13(7):787. PubMed ID: 20581813
    [No Abstract]   [Full Text] [Related]  

  • 30. Ribonucleic acid interference: the relevance of molecular targeting and therapeutics to neurosurgical practice.
    Federici T; Boulis NM
    Clin Neurosurg; 2007; 54():110-7. PubMed ID: 18504906
    [No Abstract]   [Full Text] [Related]  

  • 31. [Children with neurodegenerative disease].
    Kanavin ØJ; Strømme P
    Tidsskr Nor Laegeforen; 2010 Aug; 130(15):1489-92. PubMed ID: 20706313
    [No Abstract]   [Full Text] [Related]  

  • 32. Congenital lactic acidosis: evaluation of the properties of the a199t natural variant of human pyruvate dehydrogenase e1alpha by in vitro mutation.
    Wu YG; Widjaja SL; Huang CY; Li W; Nixon PF; Duggleby RG
    Mol Genet Metab; 2001 Mar; 72(3):269-72. PubMed ID: 11243735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome.
    Bijarnia S; Shaw P; Vimpani A; Smith R; Pacey V; O'Grady H; Christodoulou J; Sillence D
    J Paediatr Child Health; 2009; 45(7-8):469-72. PubMed ID: 19712183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction to the special issue of brain structure and function on transgenic modeling of neurodegenerative disorders.
    Hof PR; Elder GA
    Brain Struct Funct; 2010 Mar; 214(2-3):89-90. PubMed ID: 20169361
    [No Abstract]   [Full Text] [Related]  

  • 35. Epigenetic targets for the treatment of neurodegenerative diseases.
    Peedicayil J
    Clin Pharmacol Ther; 2016 May; 99(5):481. PubMed ID: 26669276
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurodegeneration: etiologies and new therapies.
    Tan EK; Srivastava AK; Arnold WD; Singh MP; Zhang Y
    Biomed Res Int; 2015; 2015():272630. PubMed ID: 25685777
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel mutation (P316L) in a female with pyruvate dehydrogenase E1 alpha deficiency.
    Takakubo F; Thorburn DR; Brown RM; Brown GK; Dahl HH
    Hum Mutat; 1995; 6(3):274-5. PubMed ID: 8535453
    [No Abstract]   [Full Text] [Related]  

  • 38. Towards gene therapy of neurodegenerative disease.
    Federoff HJ; Atkinson M
    Prog Brain Res; 1998; 117():503-10. PubMed ID: 9932428
    [No Abstract]   [Full Text] [Related]  

  • 39. Nutraceuticals and prevention of neurodegeneration.
    Magrone T; Jirillo E
    Curr Pharm Des; 2012; 18(1):2-3. PubMed ID: 22211684
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurodegenerative disorders: from molecules to man (part 2).
    Di Matteo V; Esposito E; Di Giovanni G
    CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):1-2. PubMed ID: 18289025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.